Analysis on the Problems and Countermeasures of R&D Information Disclosure in Pharmaceutical Listed Enterprises
DOI: 10.23977/acccm.2023.051118 | Downloads: 9 | Views: 271
Author(s)
Liu Yunjie 1
Affiliation(s)
1 Zibo Vocational Institute, Zibo, China
Corresponding Author
Liu YunjieABSTRACT
The research and development capabilities of the pharmaceutical industry are crucial for the development of enterprises, but the content of research and development information disclosed by enterprises to the public is uneven, and there are some problems that are not conducive to the protection of investors' interests and the effective operation of the market. Based on the theories of information asymmetry and signal transmission related to agency and information disclosure, and using literature research, text analysis, and case study methods, this paper analyzes the R&D information disclosure status of listed companies in the pharmaceutical industry. The study found that there are many problems with R&D information of enterprises in the pharmaceutical industry. For example, some companies’ disclosure of R&D information is insufficient and incomplete; Some companies lack consistency in disclosure of R&D information and do not disclose specific R&D information. At the time of investment capitalization, 3. Some companies have data errors in the disclosure of R&D information, and even the final profits are calculated through false disclosure of R&D information. In response to such problems, an analysis of the reasons is conducted from both internal and external aspects of the enterprise. Based on the analysis of the current status and reasons of R&D information disclosure, optimization suggestions are put forward. This article not only hopes to help the industry improve R&D information disclosure rules, but also hopes to increase awareness of the importance of corporate R&D information disclosure and protect the interests of investors.
KEYWORDS
R&D Information; Information disclosure; The pharmaceutical industryCITE THIS PAPER
Liu Yunjie, Analysis on the Problems and Countermeasures of R&D Information Disclosure in Pharmaceutical Listed Enterprises. Accounting and Corporate Management (2023) Vol. 5: 123-127. DOI: http://dx.doi.org/10.23977/acccm.2023.051118.
REFERENCES
[1] Feng Jing, Xu Bai. Institutional Environment, Quality of Intangible Asset Information Disclosure, and Financing Constraints - Empirical Evidence from the Growth Enterprise Market [J]. Special Economic Zone, 2017 (01): 43-50
[2] Han Peng, Yue Yuanyuan. Research on the Economic Consequences of Information Disclosure of Enterprise Innovation Behavior - Empirical Evidence from the Growth Enterprise Market [J]. Accounting Research, 2016: 49-55
[3] Zhang Wenfei, Jin Xiangyi. How Information Disclosure Affects Enterprise Innovation: Facts and Mechanisms - Based on Micro Data Analysis of Listed Companies on the Shenzhen Stock Exchange [J]. World Economic Review, 2018 (06): 102-119
[4] Wu Yanhua. Research on the Impact of Information Disclosure of Listed Companies on Corporate Value on the Growth Enterprise Market: A Life Cycle Perspective [J]. Market Modernization, 2018: 89-90
[5] Wang Qian. Research on the Relationship between Information Disclosure Quality and Company Performance [J. Financial Theory and Practice, 2008:6-70
[6] Wang Rui. Discussion on the Problems and Countermeasures of Accounting Information Disclosure in Listed Companies - Based on the Perspective of Internal Corporate Governance [J] Economic Research Guide, 2014 (06): 186-187.
Downloads: | 13501 |
---|---|
Visits: | 181974 |
Sponsors, Associates, and Links
-
Information Systems and Economics
-
Accounting, Auditing and Finance
-
Industrial Engineering and Innovation Management
-
Tourism Management and Technology Economy
-
Journal of Computational and Financial Econometrics
-
Financial Engineering and Risk Management
-
Social Security and Administration Management
-
Population, Resources & Environmental Economics
-
Statistics & Quantitative Economics
-
Agricultural & Forestry Economics and Management
-
Social Medicine and Health Management
-
Land Resource Management
-
Information, Library and Archival Science
-
Journal of Human Resource Development
-
Manufacturing and Service Operations Management
-
Operational Research and Cybernetics